Fora Capital, LLC Edwards Lifesciences Corp Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $2.51 Million - $3.16 Million	-40,642 Reduced 54.03%	34,582 $2.64 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $5.21 Million - $7.02 Million	75,224 New	75,224 $5.21 Million
Q4 2022 Feb 08, 2023	BUY	$68.3 - $87.44 $1.86 Million - $2.38 Million	27,178 Added 118.52%	50,109 $3.74 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $795,776 - $1.04 Million	9,661 Added 72.8%	22,931 $1.9 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $1.15 Million - $1.7 Million	13,270 New	13,270 $1.26 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $147,466 - $187,660	-2,057 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $138,209 - $179,864	2,057 New	2,057 $164 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.